Pharmaron Releases 2026 Interim Report Online and Opens Printed Copy Requests

Bulletin Express09-23

Pharmaron Beijing Co., Ltd. (Pharmaron) announced that its 2026 Interim Report has been published on 23 September 2026. The English version is accessible on both the company’s website (www.pharmaron.com) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk).

Non-registered H-share holders who prefer hard copies can obtain the document—and all future corporate communications—by completing and returning a request form to the company’s H-share registrar, Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong). Local mailings require no postage when the provided mailing label is used.

Shareholders may direct related enquiries to the dedicated hotline at +852 2980 1333 between 9:00 a.m. and 5:00 p.m., Monday to Friday (excluding Hong Kong public holidays), or via email at 3759-ecom@vistra.com.

The notification was issued under the authority of Pharmaron’s Board and signed by Chairman Dr. Lou Boliang.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116685261?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-23 18:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116685261","market":"hk","top_or_hot":-1,"title":"Pharmaron Releases 2026 Interim Report Online and Opens Printed Copy Requests","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. (Pharmaron) announced that its 2026 Interim Report has been published on 23 September 2026. The English version is accessible on both the company’s website (www.pharmaron.com) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk).</p>\n<p>Non-registered H-share holders who prefer hard copies can obtain the document—and all future corporate communications—by completing and returning a request form to the company’s H-share registrar, Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong). Local mailings require no postage when the provided mailing label is used.</p>\n<p>Shareholders may direct related enquiries to the dedicated hotline at +852 2980 1333 between 9:00 a.m. and 5:00 p.m., Monday to Friday (excluding Hong Kong public holidays), or via email at 3759-ecom@vistra.com.</p>\n<p>The notification was issued under the authority of Pharmaron’s Board and signed by Chairman Dr. Lou Boliang.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Releases 2026 Interim Report Online and Opens Printed Copy Requests</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Releases 2026 Interim Report Online and Opens Printed Copy Requests\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-23 18:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. (Pharmaron) announced that its 2026 Interim Report has been published on 23 September 2026. The English version is accessible on both the company’s website (www.pharmaron.com) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk).</p>\n<p>Non-registered H-share holders who prefer hard copies can obtain the document—and all future corporate communications—by completing and returning a request form to the company’s H-share registrar, Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong). Local mailings require no postage when the provided mailing label is used.</p>\n<p>Shareholders may direct related enquiries to the dedicated hotline at +852 2980 1333 between 9:00 a.m. and 5:00 p.m., Monday to Friday (excluding Hong Kong public holidays), or via email at 3759-ecom@vistra.com.</p>\n<p>The notification was issued under the authority of Pharmaron’s Board and signed by Chairman Dr. Lou Boliang.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1116685261","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116685261","pubTimestamp":1790157771,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. (Pharmaron) announced that its 2026 Interim Report has been published on 23 September 2026. The English version is accessible on both the company’s website...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成在线发布 2026 年中期报告并开放印刷版请求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. (Pharmaron) announced that its 2026 Interim Report has been published on 23 September 2026. The English version is accessible on both the company’s website (www.pharmaron.com) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk).\nNon-registered H-share holders who prefer hard copies can obtain the document—and all future corporate communications—by completing and returning a request form to the company’s H-share registrar, Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong). Local mailings require no postage when the provided mailing label is used.\nShareholders may direct related enquiries to the dedicated hotline at +852 2980 1333 between 9:00 a.m. and 5:00 p.m., Monday to Friday (excluding Hong Kong public holidays), or via email at 3759-ecom@vistra.com.\nThe notification was issued under the authority of Pharmaron’s Board and signed by Chairman Dr. Lou Boliang.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116685261","isCrawlerRequest":true}